Seeking Alpha

ZoeZoe

ZoeZoe
Send Message
View as an RSS Feed
View ZoeZoe's Comments BY TICKER:
Latest  |  Highest rated
  • What Happens To Questcor Now? [View article]
    I'm ready for the bounce anytime now.
    Sep 27 06:10 PM | Likes Like |Link to Comment
  • In The Wake Of An FDA Probe, It's Time Questcor Shareholders Begin To Consider Alternatives [View article]
    the 5% (see above) is their Aetna biz, Acthar is 100% of their profits.
    Sep 25 02:16 AM | Likes Like |Link to Comment
  • Sunesis Poised For Run-Up Into Phase III Interim Analysis Next Month [View article]
    So, the sample size was increased. Why is this typically done? What does it indicate, if anything? The stock has taken the express.
    Sep 24 01:06 AM | Likes Like |Link to Comment
  • Delcath Is About To Change The Way We Treat Liver Cancer [View article]
    European sales do seem underwhelming. Any reason for this?
    Sep 23 11:31 PM | Likes Like |Link to Comment
  • Neurocrine Still Looks Significantly Underrated [View article]
    Where is Novartis' Relaxin? Finished phase 3 but not yet approved?
    I assume there's room for multiple drugs for this indication, ADHF.
    Sep 22 12:28 AM | Likes Like |Link to Comment
  • Led By Vibex MTX, Antares' Pipeline Is Bursting With New Products [View article]
    Larry,

    Have you ever compared ATRS with UNIS?
    Sep 10 11:40 AM | Likes Like |Link to Comment
  • Marc Faber: Why Industrial Commodities Will Continue To Fail [View article]
    The decline in electricity usage doesn't support the 7.6% growth rate number. No one knows the true number....it could be 2.6%.

    It seems too convenient, too goldilocks for their economy to go from 10% growth to 7-8% growth and then stay at that level indefinitely.

    The massive decline in coppper/steel/coal/shi... equities also doesn't support a 7-8% number.
    Sep 10 05:08 AM | Likes Like |Link to Comment
  • Stem Cell Revolution: An Interview With Gary Rabin, Chairman And CEO Of Advanced Cell Technology [View article]
    How did this company end up selling at .08 cents with 2.2 billion shares outstanding? Unusual situation.
    Sep 7 08:35 AM | Likes Like |Link to Comment
  • A History Of Profit In Petroleo Brasileiro Petrobras [View article]
    Yes, too much gov't control, but the brazilian gov't is not Marxist. Marxist-controlled countries don't grow at 5% year after year, produce a world-class aircraft (ERJ), and dominate world orange juice, soybean, sugar cane, ethanol, and coffee production.
    Sep 4 02:49 AM | Likes Like |Link to Comment
  • Insiders Persistent At Celsion [View article]
    Puzzlekeeper,

    I think the new therapeutics are arriving now, not in 5 or 10 years. In fact, Gleevac (Novartis/ AML) has been around for years now.
    Sep 2 01:23 PM | Likes Like |Link to Comment
  • Endocyte Gets Big Deal But More Validation Needed [View article]
    Truffel,
    If you are going to criticize the author's interpretation of clinical data, you should at least spell "miss-understanding" correctly.
    Sep 2 05:11 AM | Likes Like |Link to Comment
  • Northwest Biotherapeutics' DCVax Cancer Vaccines Could Lead To A Sea Change In Cancer Treatment [View article]
    Celldex has a glioblastoma vaccine called Rindopepimut (Cdx-110) in Phase 3.
    My understanding is that it is distinct from the Dendreon/Provenge model and is targeting a specific population (EGFRvIII-positive patients....roughly 30% of GSM patients have this mutation).

    Have you seen their phase 2 results Mr. Smith? Any thoughts vis-a-vis IMUC, NWBO?

    Rob
    Aug 30 06:52 AM | Likes Like |Link to Comment
  • FDA Grants Dynavax Regular Review For Heplisav [View article]
    Thanks Ted.
    Aug 27 11:43 AM | Likes Like |Link to Comment
  • FDA Grants Dynavax Regular Review For Heplisav [View article]
    Does Dvax have patents for the vaccine? Until when?

    BTW, if you believe in this company now is probably the time to buy at $3.40 -$3.50. If it falls meaningfully below this level this could indicate that something is amiss. my .02
    Aug 27 08:45 AM | Likes Like |Link to Comment
  • FDA Grants Dynavax Regular Review For Heplisav [View article]
    I am a biotech novice so please excuse if my question is simple.....As I understand the situation this DVAX HepB vaccine is only being approved for 18+ yr olds, but the biggest market for HepB vaccines is babies. Do they plan to target that population in the future and if so what additional trials are necessary? How does one ethically do testing on babies?
    Aug 27 05:45 AM | Likes Like |Link to Comment
COMMENTS STATS
149 Comments
147 Likes